Huimin Kong

sun yat -sen university

H指数:35

被引数:3,983

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nanovescicles integrating PD-1-mediated targeting and CRISPR/Cas9-based CD47 editing for dual immune checkpoint blockade

纳米囊泡整合PD-1介导的靶向和CRISPR/Cas9介导的CD47编辑以实现双重免疫检查点阻断

Journal of Controlled Release

IF11.5

2025-11-290

PRE

Immuno-Packed T-Cell-Fusogenic Liposome Empowers Adoptive T Cell Therapy for Solid Tumor Treatment

免疫增强型T细胞融合脂质体赋能用于实体瘤治疗的适应性T细胞疗法

Advanced Materials

IF26.8

2025-10-070

PRE

p14ARF interacts with γ-H2AX and is involved in the DNA damage response

p14ARF与γ-H2AX相互作用，并参与DNA损伤应答。

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

IF2.2

2025-06-010

PRE

Complement opsonized protein corona activated by precoated immunoglobulin enables neutrophil-hitchhiking for rapid and enhanced drug delivery for acute liver failure recovery

由预涂免疫球蛋白激活的补体调理蛋白冠使中性粒细胞搭便车能够快速和增强药物递送，用于急性肝衰竭的恢复

NANO TODAY

IF10.9

2024-12-010

PRE

Mix-mode fracture behavior in asphalt concrete: Asymmetric semi-circular bending testing and random aggregate generation-based modelling

沥青混凝土中的混合模式断裂行为: 非对称半圆弯曲测试和基于随机骨料生成的建模

CONSTRUCTION AND BUILDING MATERIALS

IF8

2024-08-011

PRE

An antifouling membrane-fusogenic liposome for effective intracellular delivery in vivo

NATURE COMMUNICATIONS

IF15.7

2024-05-205

OAAI

Functionalized extracellular nanovesicles as advanced CRISPR delivery systems

BIOMATERIALS SCIENCE

IF5.7

2024-01-014

PRE

CRISPR/Cas detection with nanodevices: moving deeper into liquid biopsy

CHEMICAL COMMUNICATIONS

IF4.2

2024-01-018

PRE

Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy

工程纳米材料增强CRISPR/Cas9基因编辑用于癌症治疗

ADVANCED MATERIALS

IF26.8

2023-12-1215

PRE

Hepatocyte-confined CRISPR/Cas9-based nanocleaver precisely eliminates viral DNA for efficient and safe treatment of hepatitis B virus infection

肝细胞限制的CRISPR/Cas9-based纳米切割精确消除病毒DNA的高效和安全的治疗乙型肝炎病毒感染

NANO TODAY

IF10.9

2023-12-019

PRE

Platelet dropping, bleeding and new treatment requirements in ITP patients after inactivated COVID-19 vaccination

ITP患者新型冠状病毒肺炎灭活疫苗接种后血小板脱落、出血及新的治疗要求

IMMUNOLOGY LETTERS

IF2.8

2023-12-012

PRE

A LIGHTFUL nanomedicine overcomes EGFR-mediated drug resistance for enhanced tyrosine-kinase-inhibitor-based hepatocellular carcinoma therapy

一种轻盈的纳米药物克服了EGFR介导的耐药性，以增强基于酪氨酸激酶抑制剂的肝细胞癌治疗

BIOMATERIALS

IF12.9

2023-11-0115

PRE

Anti-phagocytosis-blocking repolarization-resistant membrane-fusogenic liposome (ARMFUL) for adoptive cell immunotherapy

抗吞噬阻断复极化抗膜融合脂质体 (ARMFUL) 用于过继细胞免疫治疗

SCIENCE ADVANCES

IF12.5

2023-08-1116

OAAI

Membrane-Fusion-Mediated Multiplex Engineering of Tumor Cell Surface Glycans for Enhanced NK Cell Therapy

ADVANCED MATERIALS

IF26.8

2023-01-1535

PRE

A Retrospective Study on Clinical Features of Childhood Moyamoya Disease

PEDIATRIC NEUROLOGY

IF2.1

2023-01-011

PRE

Multi-scale finite element simulation of asphalt mixture anti-cracking performance

THEORETICAL AND APPLIED FRACTURE MECHANICS

IF5.6

2022-10-0119

PRE

Membrane-fusogenic biomimetic particles: a new bioengineering tool learned from nature

膜融合仿生颗粒: 从大自然中学到的一种新的生物工程工具

JOURNAL OF MATERIALS CHEMISTRY B

IF5.7

2022-01-0118

PRE

Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma

ADVANCED SCIENCE

IF14.1

2021-10-1955

General Route to Colloidal Nanocrystal Clusters with Precise Hierarchical Control via Star-like Nanoreactors

LANGMUIR

IF3.9

2021-08-256

PREAI

Confined Unimolecular Micelles for Precisely Controlled In Situ Synthesis of Stable Ultrasmall Metal Nanocluster Assemblies

CHEMISTRY OF MATERIALS

IF7

2021-06-1422

PREAI

Huimin Kong

个人简介

教育背景

工作经历

荣誉奖项

研究方向